A detailed history of Bowling Portfolio Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Bowling Portfolio Management LLC holds 15,450 shares of ABBV stock, worth $2.78 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares
15,450
Previous 26,516 41.73%
Holding current value
$2.78 Million
Previous $4.06 Million 48.93%
% of portfolio
0.57%
Previous 1.02%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 04, 2022

SELL
$134.21 - $153.93 $1.49 Million - $1.7 Million
-11,066 Reduced 41.73%
15,450 $2.07 Million
Q2 2022

Jul 21, 2022

SELL
$137.62 - $174.96 $154,134 - $195,955
-1,120 Reduced 4.05%
26,516 $4.06 Million
Q1 2022

Apr 12, 2022

SELL
$131.98 - $163.75 $221,462 - $274,772
-1,678 Reduced 5.72%
27,636 $4.48 Million
Q4 2021

Jan 25, 2022

SELL
$107.43 - $135.93 $51,673 - $65,382
-481 Reduced 1.61%
29,314 $3.97 Million
Q3 2021

Oct 21, 2021

BUY
$106.4 - $120.78 $7,767 - $8,816
73 Added 0.25%
29,795 $3.21 Million
Q2 2021

Jul 30, 2021

SELL
$105.21 - $117.21 $23,882 - $26,606
-227 Reduced 0.76%
29,722 $3.35 Million
Q1 2021

Apr 19, 2021

BUY
$102.3 - $112.62 $491,040 - $540,576
4,800 Added 19.09%
29,949 $3.24 Million
Q4 2020

Jan 15, 2021

SELL
$80.49 - $108.67 $160,577 - $216,796
-1,995 Reduced 7.35%
25,149 $2.7 Million
Q3 2020

Oct 15, 2020

BUY
$85.91 - $100.83 $1.8 Million - $2.12 Million
21,006 Added 342.23%
27,144 $2.38 Million
Q2 2020

Jul 21, 2020

BUY
$73.37 - $98.18 $143,218 - $191,647
1,952 Added 46.63%
6,138 $603,000
Q1 2020

May 05, 2020

BUY
$64.5 - $97.79 $1,548 - $2,346
24 Added 0.58%
4,186 $319,000
Q4 2019

Jan 17, 2020

SELL
$72.13 - $90.25 $1,370 - $1,714
-19 Reduced 0.45%
4,162 $369,000
Q3 2019

Oct 15, 2019

SELL
$62.98 - $75.72 $2.95 Million - $3.55 Million
-46,875 Reduced 91.81%
4,181 $317,000
Q2 2019

Jul 25, 2019

SELL
$65.7 - $83.98 $53,611 - $68,527
-816 Reduced 1.57%
51,056 $3.71 Million
Q1 2019

Apr 18, 2019

SELL
$77.14 - $90.79 $1.01 Million - $1.19 Million
-13,073 Reduced 20.13%
51,872 $4.18 Million
Q4 2018

Jan 17, 2019

SELL
$77.85 - $96.01 $302,836 - $373,478
-3,890 Reduced 5.65%
64,945 $5.99 Million
Q3 2018

Oct 18, 2018

BUY
$88.91 - $98.84 $187,600 - $208,552
2,110 Added 3.16%
68,835 $6.51 Million
Q2 2018

Aug 06, 2018

SELL
$89.78 - $106.23 $65,808 - $77,866
-733 Reduced 1.09%
66,725 $6.18 Million
Q1 2018

Apr 25, 2018

BUY
$92.01 - $123.21 $1.43 Million - $1.91 Million
15,541 Added 29.93%
67,458 $6.39 Million
Q4 2017

Jan 22, 2018

BUY
$89.56 - $98.21 $4.11 Million - $4.51 Million
45,886 Added 760.84%
51,917 $5.02 Million
Q3 2017

Oct 16, 2017

BUY
$69.85 - $89.22 $421,265 - $538,085
6,031
6,031 $536,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Bowling Portfolio Management LLC Portfolio

Follow Bowling Portfolio Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bowling Portfolio Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bowling Portfolio Management LLC with notifications on news.